We advocate for policies by the government and practices by manufacturers and users of medical batteries for medical device design to incorporate removable batteries. Implementing new regulations that mandate the removability of batteries from medical devices after usage addresses critical safety, environmental, and biohazard risks and simplifies end-of-life management....

Radar technology enables contactless sleep monitoring of respiration, heart rate, movement, and sleep staging with over 90% accuracy across 78 studies. These physiological signals change during nocturnal hypoglycemia, positioning radar as a promising indirect detection tool — particularly where wearables are impractical. Clinical validation pairing radar with glucose measurement is now needed.

Real-world use of diabetes technologies, such as continuous glucose monitoring, automated insulin delivery, smart pens, and green diabetes approaches, confirms and extends RCT evidence. Survey-based data from Germany, Austria, and Switzerland highlight benefits, dropout reasons, age and type 2–specific issues, and system-level barriers, guiding targeted improvements in diabetes care.

A study of 70 gastric bypass patients found that Dexcom G6 CGMs are less accurate during rapid post-meal glucose drops – common in this population. With a ~10-minute lag and elevated readings at glucose lows, CGMs should be interpreted cautiously for diagnosis and management.

This German survey of 594 healthcare providers found that only 11% of type 1 diabetes patients used automated insulin delivery (AID) systems in 2022, despite clear benefits. Key barriers included lack of training materials, body image concerns, and insufficient team education. Most providers anticipated growing educational demands as AID adoption increases.

Analyzing 2,056 people with diabetes (ages 2–88) across Germany, Austria, and Switzerland, this real-world study found diabetes technologies are widely used across all age groups. CGM use was consistently high in type 1 diabetes, AID use declined after age 70, yet older adults showed comparable glycemic outcomes and high satisfaction.

This multinational survey of 1,294 healthcare providers and 2,535 people with diabetes across four European countries found high overall satisfaction with AID systems, yet 22% of eligible patients rejected them and 8% discontinued use. Unrealistic expectations, lack of trust, and technical issues were the strongest predictors of poor outcomes.

replace em with en dash11:18 AMClaude responded: Insulin must stay cold to remain effective, but real-world storage conditions – especially in warmer climates with limited cold chain access – can compromise i…Insulin must stay cold to remain effective, but real-world storage conditions – especially in warmer climates with limited cold chain access – can compromise its biological activity. Despite growing climate and equity concerns, evidence on how everyday storage affects insulin's potency remains scarce. The authors call for holistic, real-world research.

Smart pens remain significantly underutilized despite strong HCP support: only 4–15% of type 1 and 3–6% of type 2 patients currently use them, versus indicated rates of 51–73%. Top valued features are missed-dose reminders and bolus suggestions. Main barriers: preference for disposable pens, limited device options, and cost.

Gut microbiota shapes skeletal adaptation to diet-induced obesity: gnotobiotic mice colonized with Oligo-MM12 developed increased cortical thickness and trabecular area under high-fat diet, while germ-free mice did not, despite similar weight gain. Distinct metabolomic signatures and reduced β-CTX in colonized mice suggest microbiota-driven metabolic reprogramming suppresses bone resorption, linking gut microbes to the gut–bone axis.

In menstruating individuals with type 1 diabetes, hormonal fluctuations across the menstrual cycle may alter insulin sensitivity and glycemia, despite advances in automated insulin delivery (AID) systems. This study aimed to characterize glycemic patterns, insulin requirements, and insulin sensitivity across menstrual cycle phases.

The performance of continuous glucose monitoring (CGM) systems is difficult to compare due to different study designs and a lack of head-to-head studies. This study evaluated the performance of FreeStyle Libre 3 (FL3), Dexcom G7 (DG7), and Medtronic Simplera (MSP) against different comparator methods and during clinically relevant glycemic scenarios.

In continuous glucose monitoring (CGM) system performance studies, it is common to implement specific procedures for manipulating the participants’ blood glucose (BG) levels during the collection of comparator BG measurements. Recently, such a procedure was proposed by a group of experts, and this study assessed its ability to produce combinations of BG levels and rates of change (RoCs) with certain characteristics.

Glucose is an essential molecule in energy metabolism. Dysregulated glucose metabolism, the defining feature of diabetes, requires active monitoring to prevent significant morbidity and mortality. Current technologies for intermittent and continuous glucose measurement are invasive. Non-invasive glucose measurement would eliminate this barrier towards making glucose monitoring more accessible, extending the benefits from people living with diabetes to prediabetes and the healthy. We developed and investigated a spectroscopy-based system for measuring glucose non-invasively and without per-person calibration.

Nocturnal hypoglycemia poses significant risks to individuals with insulin-treated diabetes, impacting health and quality of life. Although continuous glucose monitoring (CGM) systems reduce these risks, their poor accuracy at low glucose levels, high cost, and availability limit their use. This study examined physiological biomarkers associated with nocturnal hypoglycemia and evaluated the use of machine learning (ML) to detect hypoglycemia during nighttime sleep using data from consumer-grade smartwatches.

Burnout affects >50% of physicians and nurses. Spotlight-AQ is a personalized digital health platform designed to improve routine diabetes visits. We assessed cost-effectiveness, visit length, and association with health care professional (HCP) burnout.

This study analyzed the differences in continuous glucose monitoring (CGM)-derived metrics among three current-generation systems and evaluated their impact on therapeutic decision-making.

Incorporating sex-specific factors in diabetes research and treatment is essential for advancing precision medicine. There are critical gaps in understanding and applying sex-related differences. Female-specific diabetes pathophysiology manifests in three major areas: life cycle phases (including puberty, pregnancy, and menopause), lifestyle factors (such as responses to nutrition and physical activity), and insulin pharmacology. These elements significantly affect insulin sensitivity and glycemic control in women, yet are frequently underrepresented or ignored in both research and clinical practice. Greater research and clinical focus across these domains is needed to better understand and address sex-based differences in diabetes. Identifying and filling evidence gaps will support more systematic and effective care.

Der Einsatz von KI (künstliche Intelligenz) in der Diabetologie ist an komplexe rechtliche, regulatorische und ethische Rahmenbedingungen gebunden. Im europäischen Kontext sind dabei die Medizinprodukte- (MDR) und die KI-Verordnung besonders wichtig, ergänzt durch internationale Normen, nationale Gesetze und Datenschutzvorgaben wie die Datenschutz-Grundverordnung (DSGVO). Für eine verantwortungsvolle Implementierung sind zudem ethische Leitlinien, wissenschaftliche Positionspapiere sowie die Perspektiven der Nutzer:innen zentral.

The FreeStyle Libre 3 (FSL3) continuous glucose monitoring (CGM) system provides both auto-logged glucose values (AL) and current displayed glucose values (CUR). These values are often assumed to be interchangeable; however, discrepancies and their clinical relevance remain underexplored.

Most individuals with type 1 diabetes (T1D) worldwide continue to be managed with multiple daily injections or sensor-augmented pumps. Decision-support systems (DSSs) have emerged as cost-effective tools to enhance treatment adherence and glucose control. We conducted a randomized, open-label, parallel-group study to evaluate STUDIA, a DSS incorporating a digital twin-enabled simulation-assisted bolus calculator. Twenty-eight participants with T1D used either the simulation-assisted calculator or traditional carbohydrate counting for prandial insulin dosing, with glucose monitored using Freestyle Libre.

Continuous glucose monitoring (CGM) systems are essential tools for modern diabetes care. However, the assessment of their analytical performance has been hindered by a lack of standardization. This poses challenges for the field, as the choice of study procedures and evaluation methods can influence the observed performance, further complicating the comparisons between CGM systems and confounding the interpretation and use of CGM metrics as research outcomes. To address this issue, the Working Group on CGM of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) has developed a comprehensive guideline for the clinical assessment of CGM systems. The guideline defines requirements for study design and procedures, characteristics of comparator measurements, minimum requirements for accuracy, and performance characterization.

This multinational survey of people with type 1 diabetes found that 32% struggle with insulin storage during travel and 28% recall heat-related incidents. Furthermore, 10% reported unexplained hyperglycemia despite proper use, often linking variability to stress or medications.

The treatment of diabetes has changed fundamentally, with patients now actively involved in their self-management. Digitalization plays a central role in this, from glucose measurement to automated insulin delivery. These offer not only informative but also motivational benefits for those affected. Online communities, influencers, and apps promote exchange and support diabetes self-management. Social media plays an important role in the exchange of information and experiences. Those affected can share their thoughts, experiences, and emotions, which leads to increased self-efficacy and motivation. The increasing importance of the patient perspective is reflected in studies that consider person-reported outcomes (PROs) such as quality of life and diabetes distress.

An error grid compares measured versus reference glucose concentrations to assign clinical risk values to observed errors. Widely used error grids for blood glucose monitors (BGMs) have limited value because they do not also reflect clinical accuracy of continuous glucose monitors (CGMs).

Considering sex as a biological variable in modern digital health solutions, we investigated sex-specific differences in the trajectory of four physiological parameters across a COVID-19 infection.

When dealing with start-ups, you keep seeing the same “mistakes,” especially those that do not know how to develop a medical device and document it accordingly. The topic of ISO 13485:2016 and/or FDA 21 CFR Part 820 is often not known; however, it is not that difficult if one understands the logic behind it.

To evaluate the relationship between breath volatile organic compounds (VOCs) and glycaemic states in individuals with type 1 diabetes (T1D), focusing on identifying specific VOCs as biomarkers for hypoglycaemia to offer a non-invasive diabetes-monitoring method.

Comparing the performance of different continuous glucose monitoring (CGM) systems is challenging due to the lack of comprehensive guidelines for clinical study design. In particular, the absence of concise requirements for the distribution of comparator (reference) blood glucose (BG) concentrations and their rate of change (RoC) that are used to evaluate CGM performance, impairs comparability. For this article, several experts in the field of CGM performance testing have collaborated to propose characteristics of the distribution of comparator measurements that should be collected during CGM performance testing.

This narrative review summarises the current evidence on the role of dietary fibre in enteral nutrition in the prevention and therapy of sepsis, with a focus on critically ill patients. The aim is to discuss the implications for clinical practice and identify future directions for policy and research.

Dendritic cells (DCs) actively sample and present antigen to cells of the adaptive immune system and are thus vital for successful immune control and memory formation. Immune cell metabolism and function are tightly interlinked, and a better understanding of this interaction offers potential to develop immunomodulatory strategies. However, current approaches for assessing the immune cell metabolome are often limited by end-point measurements, may involve laborious sample preparation, and may lack unbiased, temporal resolution of the metabolome.

Basic vital signs change during normal pregnancy as they reflect the adaptation of maternal physiology. Electronic wearables like fitness bracelets have the potential to provide vital signs continuously in the home environment of pregnant women.

Hormonal fluctuations across the menstrual cycle lead to multiple changes in physiological parameters such as body temperature, cardiovascular function, respiratory rate and perfusion. Electronic wearables analyzing those parameters might present a convenient alternative to urinary ovulation tests for predicting the fertile window.

To assess the compliance of “integrated” continuous glucose monitoring (CGM) systems with U.S. Food and Drug Administration requirements, the calculation of confidence intervals (CIs) on agreement rates (ARs), that is, the percentage of CGM measurements lying within a certain deviation of a comparator method, is stipulated. However, despite the existence of numerous approaches that could yield different results, a specific procedure for calculating CIs is not described anywhere. This report, therefore, proposes a suitable statistical procedure to allow transparency and comparability between CGM systems.

The relevance of extracellular magnesium in cellular immunity remains largely unknown. Here, we show that the co-stimulatory cell-surface molecule LFA-1 requires magnesium to adopt its active conformation on CD8+ T cells, thereby augmenting calcium flux, signal transduction, metabolic reprogramming, immune synapse formation, and, as a consequence, specific cytotoxicity. Accordingly, magnesium-sufficiency sensed via LFA-1 translated to the superior performance of pathogen- and tumor-specific T cells, enhanced effectiveness of bi-specific T cell engaging antibodies, and improved CAR T cell function.

Goblet cells secrete mucin to create a protective mucus layer against invasive bacterial infection and are therefore essential for maintaining intestinal health. However, the molecular pathways that regulate goblet cell function remain largely unknown. Although GPR35 is highly expressed in colonic epithelial cells, its importance in promoting the epithelial barrier is unclear.

The accuracy of continuous glucose monitoring (CGM) systems is crucial for the management of glucose levels in individuals with diabetes mellitus. However, the discussion of CGM accuracy is challenged by an abundance of parameters and assessment methods. The aim of this article is to introduce the Continuous Glucose Deviation Interval and Variability Analysis (CG-DIVA), a new approach for a comprehensive characterization of CGM point accuracy which is based on the U.S. Food and Drug Administration requirements for “integrated” CGM systems.

In analytical performance studies, the choice of comparator method plays an important role, as studies have shown that there exist relevant systematic differences (bias) between laboratory analyzers. The feasibility of retrospective recalibration of measurement results through comparison with methods or materials of higher metrological order to minimize bias was therefore assessed.

Serum acetate increases upon systemic infection. Acutely, assimilation of acetate expands the capacity of memory CD8+ T cells to produce IFN-γ. Whether acetate modulates memory CD8+ T cell metabolism and function during pathogen re-encounter remains unexplored. Here we show that at sites of infection, high acetate concentrations are being reached, yet memory CD8+ T cells shut down the acetate assimilating enzymes ACSS1 and ACSS2.